Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice

Identification of HER2 Low and HER2 Ultra-low Breast CancerПодробнее

#BREASTPATH Destiny of HER2/neu in the era of HER2-low in 2024Подробнее

New Perspectives on the Full Spectrum of HER2 Expression in Breast CancerПодробнее

HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review ConferenceПодробнее

Treatment Updated for HER2 Positive Breast Cancer: Changing ParadigmsПодробнее

HER2 In Breast Cancer: Testing Guidelines and New Treatment ApproachesПодробнее

Advances in HER2-positive and HER2-low Breast CancerПодробнее

HER2 Testing in Breast Cancer: Improving IHC PerformanceПодробнее

The Science of HER2-low Breast Cancer and Implications for the Pathology TeamПодробнее